IOVA

Iovance Biotherapeutics
IOVA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$577.71M
EV
$271.71M
Shares Outstanding
333.93M
Beta
1.06

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$10.70
P/E 2025E
-
P/Revenue 2025E
2.01x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Iovance Biotherapeutics, Inc.

gainify
IOVA

Iovance Biotherapeutics, Inc.

IOVA

Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company ...

Sector

Healthcare

Industry

Biotechnology

CEO

Vogt, Frederick

Employees

838

IPO Date

2010-10-15

Headquarters

825 Industrial Road, Suite 400, San Carlos, California, 94070, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on Threads
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.